These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 39288384)

  • 1. Impact of the COVID-19 pandemic on antibiotic utilization in a tertiary hospital.
    Çalişkan Demirkiran B; Gül HC; Erdem H
    J Infect Dev Ctries; 2024 Aug; 18(8):1161-1168. PubMed ID: 39288384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern of antibiotic utilisation among intensive care unit patients hospitalised in a Gauteng (South African) provincial tertiary hospital: Comparing findings before and during COVID-19.
    Spinickum L; Booth Z; Leigh-de Rapper S
    S Afr Med J; 2024 Jul; 114(7):e1812. PubMed ID: 39041519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia.
    Youssif E; Aseeri M; Khoshhal S
    J Infect Public Health; 2018; 11(4):486-490. PubMed ID: 29153444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Changes in Broad-spectrum Antimicrobial Consumption during the COVID-19 Pandemic in a Japanese Acute Tertiary-care Hospital: An Interrupted Time-series Analysis.
    Hadano Y; Ohwaki K; Suyama A; Miura A; Fujii S; Suzuki Y; Tomoda Y; Awaya Y
    Intern Med; 2024 Aug; 63(15):2125-2130. PubMed ID: 38104990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
    Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).
    Tan SH; Ng TM; Tay HL; Yap MY; Heng ST; Loo AYX; Teng CB; Lee TH
    J Glob Antimicrob Resist; 2021 Mar; 24():45-47. PubMed ID: 33307276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore.
    Ng TM; Tan SH; Heng ST; Tay HL; Yap MY; Chua BH; Teng CB; Lye DC; Lee TH
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):28. PubMed ID: 33536077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Antimicrobial utilization in a paediatric intensive care unit in India: A step towards strengthening antimicrobial stewardship practices".
    Singh MP; Gaikwad NR; Keche YN; Jindal A; Dhaneria S; Gurunthalingam MP
    PLoS One; 2024; 19(9):e0310515. PubMed ID: 39298455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital use of antibiotics in internal medicine: A cross-sectional study before, during and after the COVID-19 pandemic in a COVID-19-free ward.
    Bellanti F; Lo Buglio A; Ricci A; Aquilino A; Labbate A; Vendemiale G
    J Infect Public Health; 2024 Aug; 17(8):102490. PubMed ID: 38991413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of an antimicrobial stewardship intervention in India: Evaluation of post-prescription review and feedback as a method of promoting optimal antimicrobial use in the intensive care units of a tertiary-care hospital.
    Rupali P; Palanikumar P; Shanthamurthy D; Peter JV; Kandasamy S; Zacchaeus NGP; Alexander H; Thangavelu P; Karthik R; Abraham OC; Michael JS; Paul H; Veeraraghavan B; Chacko B; Jeyaseelan V; Alangaden G; Prentiss T; Zervos MJ
    Infect Control Hosp Epidemiol; 2019 May; 40(5):512-519. PubMed ID: 31084674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
    Bahçe YG; Acer Ö; Özüdoğru O
    Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic consumption in hospitals during COVID-19 pandemic: a comparative study.
    Hussein RR; Rabie ASI; Bin Shaman M; Shaaban AH; Fahmy AM; Sofy MR; Lattyak EA; Abuelhana A; Naguib IA; Ashour AM; Aldeyab MA
    J Infect Dev Ctries; 2022 Nov; 16(11):1679-1686. PubMed ID: 36449638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the impact of COVID-19 on antibiotic use in Canadian primary care: a matched-cohort study using EMR data.
    Morkem R; Smith G; Knight B; Wong ST; Barber D
    Antimicrob Resist Infect Control; 2024 Jul; 13(1):76. PubMed ID: 38997756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating antibiotics consumption in a tertiary care hospital in Islamabad using a WHO's defined daily dose methodology.
    Jabeen N; Ullah W; Khalid J; Samad Z
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):132. PubMed ID: 37996947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data.
    Yang X; Li X; Qiu S; Liu C; Chen S; Xia H; Zeng Y; Shi L; Chen J; Zheng J; Yang S; Tian G; Liu G; Yang L
    J Infect; 2024 Jul; 89(1):106183. PubMed ID: 38754635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The experience of an antimicrobial stewardship program and antibiotic consumption and resistance trends during the COVID-19 pandemic at a tertiary care center in Beirut.
    Haddad N; Zeenny RM; El Halabi C; Abdallah T; El Helou R; Zahreddine NK; Kanj SS; Rizk NA
    J Infect Public Health; 2024 Feb; 17(2):254-262. PubMed ID: 38128409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance patterns among critical priority pathogens in an intensive care unit at a tertiary hospital in Egypt: a descriptive analysis comparing pre- and COVID-19 eras.
    Zafer MM; Bassiouny DM; Ghosh S; Bornman C; Hussein AFA
    J Med Microbiol; 2024 Jun; 73(6):. PubMed ID: 38916589
    [No Abstract]   [Full Text] [Related]  

  • 19. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
    Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
    Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter.
    Buehrle DJ; Decker BK; Wagener MM; Adalja A; Singh N; McEllistrem MC; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.